IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC).

被引：0
|
作者：
Vogel, Arndt
Siegler, Gabriele Margareta
Siebler, Jurgen
Lindig, Udo
Schultheiss, Michael
Mueller, Tobias
Simon, Henry
Joeckel, Christiane
Mueller, Daniel Wilhelm
Al-Batran, Salah-Eddin
Saborowski, Anna
De Toni, Enrico N.
机构：
[1] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[2] Paracelsus Med Univ, Klinikum Nurnberg, Med Klin 5, Hamatol Onkol, Nurnberg, Germany
[3] Univ Klinikum Erlangen, Med Klin 1, Erlangen, Germany
[4] Univ Klinikum Jena, Klin Innere Med Hamtol Onckol 2, Jena, Germany
[5] Univ Klinikum Freiburg, Klin Innere Med 2, Freiburg, Germany
[6] Charite Univ Med Berlin CVK, Med Klin Gastroenterol Infektiol & Rheumatol, Berlin, Germany
[7] Rems Murr Klinikum Winnenden, Hamatol Onkol & Palliat Med, Winnenden, Germany
[8] Inst Klin Krebsforsch IKF Krankenhaus Nordwest, Frankfurt, Germany
[9] 2Krankenhaus Nordwest, Univ Canc Ctr Frankfurt, Frankfurt, Germany
[10] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[11] LMU Munchen, Med Klin & Poliklin 2, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4107
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO).
    Keenan, Bridget
    Griffith, Madeline J.
    Bauer, Kelly
    Bracci, Paige M.
    Behr, Spencer
    Umetsu, Sarah E.
    Gordan, John Dozier
    Ngo, Zoe
    Iqbal, Syma
    Hanna, Diana L.
    Venook, Alan P.
    El-Khoueiry, Anthony B.
    Fong, Lawrence
    Kelley, Robin Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [22] CAMRELIZUMAB COMBINED WITH LENVATINIB AND RALOX-HAIC FOR HEPATOCELLULAR CARCINOMA (HCC) IN BCLC STAGE B AND C: A PROSPECTIVE, SINGLE-ARM TRIAL (CAL ERA STUDY)
    Zang, Mengya
    Li, Yuanfeng
    Yuan, Guosheng
    Li, Qi
    Hu, Xiaoyun
    Li, Wenli
    Li, Chuanjiang
    Pang, Huajin
    HEPATOLOGY, 2024, 80 : S1967 - S1968
  • [23] Modified-dose capecitabine plus bevacizumab for the treatment of advanced/metastatic hepatocellular carcinoma (HCC): A phase II, single-arm study
    Hsu, C.
    Yang, T.
    Hsu, C.
    Toh, H.
    Epstein, R. J.
    Hsiao, L.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial
    Xu, Li
    Chen, Jinzhang
    Liu, Chang
    Song, Xiaoling
    Zhang, Yanqiao
    Zhao, Haitao
    Yan, Sheng
    Jia, Weidong
    Wu, Zheng
    Guo, Yabing
    Yang, Jiayin
    Gong, Wei
    Ma, Yue
    Yang, Xiaobo
    Gao, Zhenzhen
    Zhang, Nu
    Zheng, Xin
    Li, Mengyu
    Su, Dan
    Chen, Minshan
    BMC MEDICINE, 2024, 22 (01)
  • [25] Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study
    Hsu, Chiun
    Chang, Yi-Fang
    Yen, Chia-Jui
    Xu, Yu-Wei
    Dong, Min
    Tong, You-Zhi
    BMC MEDICINE, 2023, 21 (01)
  • [26] Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study
    Chiun Hsu
    Yi-Fang Chang
    Chia-Jui Yen
    Yu-Wei Xu
    Min Dong
    You-Zhi Tong
    BMC Medicine, 21
  • [27] IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)
    Vogel, A.
    Saborowski, A.
    Hinrichs, J.
    Ettrich, T. J.
    Ehmer, U.
    Martens, U. M.
    Mekolli, A.
    De Toni, E.
    Berg, T.
    Geissler, M.
    Maenz, M.
    Kirstein, M.
    Waldschmidt, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S1312 - S1312
  • [28] Treatment of Advanced or Metastatic Hepatocellular Cancer (HCC) Preliminary Safety Analysis of a Single-ARM Phase II Study of Bevacizumab and Rad001
    Treiber, Gerhard
    GASTROENTEROLOGY, 2010, 138 (05) : S811 - S811
  • [29] Treatment of advanced or metastatic hepatocellular cancer (HCC) - preliminary safety analysis of a single-arm phase II study of bevacizumab and RAD001
    Treiber, G.
    ONKOLOGIE, 2010, 33 : 8 - 9
  • [30] Efficacy and Safety of Zoledronic Acid Plus Sorafenib for Advanced Hepatocellular Carcinoma Patients: A Single Center, Single Arm, Phase II Clinical Trial
    Zhang, Lan
    Xie, Xiaoying
    Ren, Zheng Gang
    Sun, Hui Chuan
    HEPATOLOGY, 2018, 68 : 216A - 216A
12345